Delegated & implementing acts: EU adapts a significant number of legislative acts to the Lisbon Treaty
The Council recently adopted a regulation aligning 64 legislative acts which refer to the so-called 'regulatory procedure with scrutiny' with the Lisbon Treaty.
The Lisbon Treaty introduced a distinction between powers delegated to the Commission to adopt non-legislative acts of general application to supplement or amend certain non-essential elements of a legislative act (delegated acts) and powers conferred upon the Commission to adopt acts to ensure uniform conditions for implementing legally binding Union acts (implementing acts). This means that all existing legislative acts referring to the former 'regulatory procedure with scrutiny' have to be brought in line with the Lisbon Treaty. In some cases this has already happened. For the rest, the Council, Parliament and Commission acknowledged in the 2016 Interinstitutional Agreement on Better Law-Making the need for prompt alignment.
The regulation adopted recently covers some of the acts proposed for alignment by the Commission in 2016. In the majority of cases it replaces the regulatory procedure with scrutiny with references to delegated acts and in some cases to implementing acts.
The Council, Parliament and Commission will continue to work on the alignment of the remaining acts during the term of the next European Parliament.
- Regulation adapting a number of legal acts providing for the use of the regulatory procedure with scrutiny to Articles 290 and 291 TFEU
- Joint statement by the Parliament, the Council and the Commission
- Implementing and delegated acts (Commission webpage)
+32 (0)2 281 38 71
+32 (0)470 89 08 50
Latest News from
EC opens investigation into possible anti-competitive conduct of Amazon18/07/2019 15:25:00
The EC has opened a formal antitrust investigation to assess whether Amazon's use of sensitive data from independent retailers who sell on its marketplace is in breach of EU competition rules.
Turkish drilling activities in the Eastern Mediterranean16/07/2019 15:25:00
The Council adopted the following conclusions on the Turkish drilling activities in the Eastern Mediterranean.
Four new substances added to the Candidate List16/07/2019 13:43:00
The Candidate List of substances of very high concern (SVHCs) for authorisation now contains 201 substances.
Imports of hormone-free beef: EU-US agreement confirmed16/07/2019 11:43:00
The Council has adopted a decision on the signing of an agreement between the EU and the US on the allocation to the US of a share in the TRQ for high quality beef regarding the importation of beef from animals not treated with certain growth-promoting hormones.
EIOPA consults on the harmonisation of national insurance guarantee schemes15/07/2019 12:32:00
Tthe European Insurance and Occupational Pension Authority (EIOPA) has launched a consultation on its Advice on the harmonisation of national insurance guarantee schemes across the Member States of the European Union.
EU-U.S. trade talks: milestone reached in mutual recognition on pharmaceuticals12/07/2019 15:25:00
The EU and the USA have delivered on a significant element of the Joint Statement agreed by Presidents Juncker and Trump in July 2018. The positive transatlantic trade agenda established in the Joint Statement includes a commitment from both sides to reduce barriers and increase trade in a range of sectors, including pharmaceuticals.
Airbnb cooperates with EC and EU consumer authorities improving the way it presents offers12/07/2019 13:25:00
The EC has announced that, as a result of negotiations with Airbnb, the platform has improved and fully clarified the way it presents accommodation offers to consumers, which is now in line with the standards set in EU consumer law.
European Institute of Innovation and Technology: EC proposes strategy for 2021-202712/07/2019 11:33:00
The EC has proposed an update of the legal base of the European Institute of Innovation and Technology (EIT) as well as its new Strategic Innovation Agenda for 2021-2027.
EC approves GlaxoSmithKline's acquisition of Pfizer's Consumer Health Business with conditions11/07/2019 15:25:00
The EC has approved, under the EU Merger Regulation, the acquisition of Pfizer's Consumer Health Business by GlaxoSmithKline. The decision is conditional upon the global divestment of Pfizer's topical pain management business carried out under the ThermaCare brand.